BICO Group AB
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
BICO Group AB - overview
Established
2016
Location
Gothenburg, Västra Götaland County, Sweden
Primary Industry
Biotechnology
About
Based in Sweden, BICO Group AB specializes in life science innovations, offering cutting-edge lab automation solutions and bioprinting technologies to enhance laboratory efficiency and research capabilities across diverse markets. Founded in 2016 in Gothenburg, Sweden, BICO Group AB is focused on providing laboratory automation and bioprinting technologies. The company, led by CEO Cecilia Edebo and co-founder Erik Gatenholm, has not undergone any significant pivots in its business strategy. BICO is at the forefront of life science innovation, primarily focusing on end-to-end lab automation solutions that streamline laboratory processes and enhance research capabilities.
Their core product offerings include advanced lab automation systems and bioprinting technologies, which are designed to automate repetitive tasks, thereby increasing efficiency and precision in scientific research. The company serves a diverse client base, including research institutions, biotechnology companies, and pharmaceutical firms across multiple geographical markets such as North America, Europe, and Asia-Pacific. These products cater to various applications, such as drug development, regenerative medicine, and personalized healthcare, providing end-users with tools that facilitate the acceleration of scientific discovery. BICO generates revenue through a multifaceted business model that includes direct sales, subscriptions, and strategic partnerships.
Their transactions typically involve selling lab automation systems and bioprinting technologies directly to clients, complemented by ongoing service agreements that ensure optimal operation and maintenance of the equipment. The revenue structure is further supported by subscription-based models for software solutions that accompany their hardware offerings. This approach enables clients to continuously access updates and support, fostering long-term relationships. BICO's flagship products, recognized for their innovative technology, contribute significantly to the overall revenue, solidifying the company's position within the life sciences market.
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Diagnostic, Medical & Imaging Laboratories
Website
www.bico.com/
Verticals
3D Printing
Total Amount Raised
Subscriber access only
BICO Group AB - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Corporate Carve Out | Completed | MatTek Life Sciences | - | ||||||||
| Add-on, Corporate Carve Out | Completed | Visikol, Inc. | - |
Displaying 1 - 2 of 2
BICO Group AB - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.